Siegelin, M., Gaiser, T., Habel, A., & Siegelin, Y. (2009). Daidzein overcomes TRAIL-resistance in malignant glioma cells by modulating the expression of the intrinsic apoptotic inhibitor, bcl-2. Neuroscience Letters, 454(3), 223. https://doi.org/10.1016/j.neulet.2009.03.031
Chicago Style (17th ed.) CitationSiegelin, M.D, Timo Gaiser, Antje Habel, and Y. Siegelin. "Daidzein Overcomes TRAIL-resistance in Malignant Glioma Cells by Modulating the Expression of the Intrinsic Apoptotic Inhibitor, Bcl-2." Neuroscience Letters 454, no. 3 (2009): 223. https://doi.org/10.1016/j.neulet.2009.03.031.
MLA (9th ed.) CitationSiegelin, M.D, et al. "Daidzein Overcomes TRAIL-resistance in Malignant Glioma Cells by Modulating the Expression of the Intrinsic Apoptotic Inhibitor, Bcl-2." Neuroscience Letters, vol. 454, no. 3, 2009, p. 223, https://doi.org/10.1016/j.neulet.2009.03.031.